Evidence map›Paper›PMID 41501832›Full record

ArticleJournal of translational medicine2026

Restoring brain wiring, mobility, sleep, and lifespan with a novel repurposed modulator of voltage-gated K

Maria Dolores Setzu, Maria Antonietta Casu, Ignazia Mocci, Giuseppe Talani, Fatemah M Haidar, Fabrizio Sanna, Cristina Manis, Pierluigi Caboni, Gilles Bru-Mercier, Francesca Biggio and 10 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Maria Dolores SetzuDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Maria Antonietta CasuCNR-Institute of Translational Pharmacology, UOS of Cagliari, Cagliari, Italy.
Ignazia MocciCNR-Institute of Translational Pharmacology, UOS of Cagliari, Cagliari, Italy.
Giuseppe TalaniCNR-Institute of Neuroscience, UOS of Cagliari, Cagliari, Italy.
Fatemah M HaidarDepartment of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates.
Fabrizio SannaDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Cristina ManisDepartment of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
Pierluigi CaboniDepartment of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
Gilles Bru-MercierDepartment of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates.
Francesca BiggioDepartment of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
Manigandan KrishnanDepartment of Pediatrics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates.
Patrizia MuroniDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Bianca Maria BaroliDepartment of Life and Environmental Sciences, University of Cagliari, Cagliari, Italy.
Roberto FrauDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Luca ConcasDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Monica PulighedduDepartment of Medical Sciences and Public Health, Sleep Disorder Research Center, University of Cagliari, Cagliari, Italy.
Sandeep B SubramanyaDepartment of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates.
Paola ImbriciDepartment of Pharmacy-Drug Sciences, University of Bari ''Aldo Moro", Bari, Italy.
Maria Cristina D'AdamoDepartment of Medicine & Surgery, LUM University "Giuseppe DEGENNARO", 70010, Casamassima, (BA), Italy.
Mauro PessiaDepartment of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, 15551, United Arab Emirates. mauro.pessia@um.edu.mt.ORCID 0000-0002-2857-6795

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVoltage-gated K+ channels (Kv) regulate various essential brain functions. Cognitive impairment, intellectual disability, and sleep disruption are prevalent in Kv1.1- and Kv1.2-related channelopathies, yet the mechanistic basis is unresolved and no symptom-specific repurposing candidates for pharmacotherapy have been identified. Furthermore, the role Kv channels play in establishing synaptic wiring—the intricate network of neuron-to-neuron connections that underpins communication within the brain that is fundamental to cognitive functions—remains poorly understood at ultrastructural level.

methodWe employed a multidisciplinary experimental approach integrating ultrastructural, biochemical, electrophysiological and behavioral analyses to investigate the impact of Shaker K+ channel mutation on synaptic connections in the brain of Drosophila melanogaster flies Sh and to identify drugs with repurposing potential. In the protocerebrum, T-bars density and morphology was assessed using transmission electron microscopy while the concentration of the drug in the brain was measured by UHPLC–MS/MS. Survival and motor behavior were evaluated via lifespan and climbing assays, while sleep was quantified using the Drosophila Activity Monitoring System. The functional effects of the drug on ion channels were studied using two-electrode voltage-clamp in Xenopus laevis oocytes and whole-cell patch-clamp recordings in differentiated Neuro-2a cells. Finally, evoked post-synaptic potentials were recorded to assess neuromuscular transmission efficacy.

resultsMutant Sh flies exhibit impaired neuromuscular transmission, climbing ability, and sleep duration, ultimately shortening lifespan. We observed that all these abnormalities in Sh flies were significantly alleviated by administering low dose of ibuprofen, a widely used non-steroidal anti-inflammatory drug. Through high-resolution ultrastructural analyses, we discovered decreased density of T-bars with morphologically abnormal presynaptic bouton active zones in the brains of Sh flies which were restored by nanomolar concentrations of ibuprofen in their brains. Mechanistically, the drug increased the amplitude of both Shaker currents in Xenopus oocytes and voltage-gated K+ currents in Neuro-2a cells. Collectively, these results identify ibuprofen as a previously unrecognized modulator of Kv channels that restores neuronal network integrity compromised by Shaker K+ channel dysfunction, thereby normalizing neuromuscular signaling and enhancing motor performance, sleep, and longevity in Sh mutant flies. Notably, this study uncovers that genetically-induced dysfunction of Kv1 channels leads to disrupted brain wiring, highlighting the crucial role this K+ channel type plays in establishing proper neuron-to-neuron connections, and offer a pioneering treatment strategy for symptoms-targeted Kv1.1 channelopathies.

Indexed as

BrainChannelopathiesLongevityPotassium Channels, Voltage-GatedSleepAnimalsDrosophila melanogasterDrosophila ProteinsFemaleMutationShaker Superfamily of Potassium ChannelsDrosophila ProteinsPotassium Channels, Voltage-GatedShaker Superfamily of Potassium ChannelsSh protein, DrosophilaAgingBrain wiringIbuprofenLongevityShaker K+ channels Kv1Sleep disturbanceT-bar

Identifiers

PMID41501832
PMCPMC12910926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.